Announcements Trials
Browse Landscape

Phase

Phase 2 45Phase 3 13Phase 1/2 13Phase NA 11Phase 1 11Phase 4 3Phase EARLY_PHASE1 2Phase 2/3 2

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 3Other hematologic neoplasm 1Myeloid 1Gynecologic 1

Conditions

Breast Neoplasms 276Neoplasms 202Prostatic Neoplasms 118Polycystic Ovary Syndrome 114Colorectal Neoplasms 103Carcinoma, Hepatocellular 103Carcinoma, Non-Small-Cell Lung 88Lung Neoplasms 70Stomach Neoplasms 62Precursor Cell Lymphoblastic Leukemia-Lymphoma 60Pain 59Neoplasm Metastasis 54Multiple Myeloma 52Pancreatic Neoplasms 46Keratosis, Actinic 46Head and Neck Neoplasms 43Pain, Postoperative 42Leukemia, Myeloid, Acute 40Leiomyoma 39Recurrence 38Liver Neoplasms 38Colonic Neoplasms 37Uterine Cervical Neoplasms 35Lymphoma 35Brain Neoplasms 34Infertility 33Papillomavirus Infections 32Ovarian Neoplasms 31Lymphoma, Follicular 31Lymphoma, Non-Hodgkin 30

Interventions

eltrombopag 1Tinzaparin 1Pharmacokinetics 1Enoxaparin 1Dalteparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Interventional × Thrombocytopenia × Clear all
NCT05255003 2025-12-17

STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis

Ottawa Hospital Research Institute

Phase 4 Recruiting
50 enrolled
Classical hematology

Thrombocytopenia

NCT04861181 2025-05-22

NIRAPK

Hospices Civils de Lyon

Phase 4 Terminated
12 enrolled
Classical hematologyGynecologic

Ovarian Neoplasms, Recurrence, Thrombocytopenia

NCT01957176 2022-12-30

A Rollover Study to Provide Continued Treatment With Eltrombopag

Novartis

Phase 4 Completed
22 enrolled 9 charts
Classical hematologyMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Thrombocytopenia, Leukemia, Myeloid, Acute, Purpura, Thrombocytopenic, Idiopathic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡